U.S. Construction Stock News

Western Midstream Partners (WES) has come into focus after its subsidiary priced a $700 million senior notes offering, as investors weigh what this means for the partnership’s leverage profile and upcoming capital spending. See our latest analysis for Western Midstream Partners. Western Midstream Partners’ share price has eased over the past month, with a 30 day share price return of a 5.77% decline, even as the 1 year total shareholder return of 22% and 5 year total shareholder return of...

Quantum Computing (QUBT) is back in focus after recent trading pressure, with the stock down 6.3% over the past day and 15.5% over the past week, prompting investors to reassess its risk profile. See our latest analysis for Quantum Computing. The recent pullback fits into a mixed picture for Quantum Computing, with the 30 day share price return down 22.17%, offset by a 90 day share price return up 36.49% and a very large 3 year total shareholder return of about 7x, while the 1 year total...

In June 2026, Suburban Propane Partners, L.P. worked with ABB, Kempower, and NASCAR to power mobile DC fast charging for electric vehicles in San Diego using off-grid generators fueled by renewable propane and supported by battery storage. This collaboration highlighted how propane and renewable propane can serve as a reliable, lower-carbon energy source for temporary or hard-to-reach EV charging locations where grid access is limited or costly. We’ll now examine how showcasing renewable...

Recently, Kiniksa Pharmaceuticals was highlighted for its strong profitability, an uncommon trait among biotechs, underscoring its efficient commercialization of therapies for unmet medical needs. This recognition emphasizes how Kiniksa’s ability to generate profits in a research-intensive sector may distinguish its business model from many peers. With this renewed focus on Kiniksa’s profitability, we’ll now examine how the news shapes and reinforces the company’s broader investment...

In June 2026, Credit Acceptance Corporation entered into the Fifteenth Amendment to its Sixth Amended and Restated Credit Agreement, extending the revolving secured line of credit facility’s revolving period from June 22, 2028 to June 22, 2029 and reducing the interest margin on SOFR-based borrowings from 197.5 to 175.0 basis points, with US$270.5 million outstanding as of June 9, 2026. This extension and lower borrowing spread modestly improve funding flexibility and interest costs, which...

Corvus Pharmaceuticals (CRVS) has drawn investor interest after recent share price moves, with the stock last closing at $13.05 and a market value of about $1.09b. This highlights heightened attention on this clinical stage biopharma. See our latest analysis for Corvus Pharmaceuticals. Recent momentum in Corvus Pharmaceuticals has been strong, with a 7 day share price return of 9.57% and a year to date share price return of 78.28%. The 1 year total shareholder return of 209.98% points to a...

Cerebras Systems’ first post-IPO earnings report in June 2026 showed Q1 revenue rising to US$193.41 million, a narrower net loss of US$14.01 million, and new multi‑year AI infrastructure agreements with OpenAI and Amazon Web Services worth more than US$20 billion in aggregate. The company’s plan to lease back data center capacity as it pivots from selling chips to running an AI cloud points to a trade‑off between securing long‑term compute contracts and accepting lower gross margins in the...

Catalyst Pharmaceuticals (CPRX) has drawn investor attention after its rare-disease portfolio produced annual revenue of $596.958 million and net income of $221.323 million, putting the current share price of $31.42 into sharper focus. See our latest analysis for Catalyst Pharmaceuticals. Over the past year, Catalyst Pharmaceuticals has coupled solid reported profitability with strong momentum, with a 1-year total shareholder return of 43.54% and a 5-year total shareholder return of 442.66%...

Over the last 7 days, the United States market has experienced a 2.7% decline, yet it remains up 19% over the past year, with earnings projected to grow by 18% annually in the coming years. In this context of fluctuating short-term performance and strong long-term growth expectations, identifying undervalued stocks with discounted valuations can be an effective strategy for investors seeking to capitalize on potential market opportunities.

Over the last 7 days, the market has dropped 2.7%, contrasting with a 19% rise over the past year, and earnings are forecast to grow by 18% annually. In such a landscape, identifying stocks with strong financials becomes crucial for investors looking to capitalize on growth opportunities. While the term 'penny stocks' might seem outdated, these smaller or newer companies can offer unique value and growth potential when backed by solid fundamentals.

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it remains up by 19% over the past year with expectations of an 18% annual earnings growth in the coming years. In this context, identifying growth companies with high insider ownership can be particularly appealing as they often align management interests with shareholders and may indicate confidence in future performance.

In the United States market, recent fluctuations have seen a 2.7% drop over the last week, yet it has achieved a notable 19% increase over the past year with earnings expected to grow by 18% annually. In such dynamic conditions, selecting reliable dividend stocks like International General Insurance Holdings can offer stability and potential income for investors seeking to balance growth with consistent returns.

AvalonBay Communities (AVB) has drawn investor attention after recent trading, with the stock last closing at US$186.13. The move has prompted closer scrutiny of its performance, valuation signals and underlying apartment-focused business. See our latest analysis for AvalonBay Communities. Recent trading suggests momentum around AvalonBay Communities is improving, with a 1-day share price return of 1.38% and a 90-day share price return of 15.75%, even though the 1-year total shareholder...

With veteran investor Jeremy Grantham flagging U.S. stocks as extremely expensive based on the Buffett indicator, many investors are rethinking how much risk they really want in their portfolios. While the artificial intelligence boom has pushed market valuations higher and stirred talk of a possible bubble, some larger companies with historically low share price volatility and solid balance sheets may offer a different way to stay invested. This article looks at 3 stocks from our Low...

Alcoa Corporation recently announced that United Steelworkers union members ratified a new labor agreement covering about 965 employees at its Warrick (Indiana) and Massena (New York) smelters, effective from May 16, 2026, through May 15, 2030. This multi-year contract reduces the risk of labor disruption at two important U.S. smelters, offering greater visibility into Alcoa’s near-term operating continuity and cost planning. We’ll now examine how this newly ratified multi-year labor...

Earlier this year, Masco reported a strong first quarter, with revenues surpassing analyst expectations and solid organic revenue and EBITDA growth across its home improvement portfolio. This performance came as the broader home construction materials sector also delivered better-than-expected results and guidance, reinforcing Masco’s exposure to a healthier-than-anticipated repair and remodeling backdrop. We’ll now examine how this earnings outperformance and sector strength could influence...

Polestar Automotive Holding UK (NasdaqGM:PSNY) has been denied authorization to sell new vehicles in the U.S. from 2027 under upcoming connected vehicle regulations. The U.S. Department of Commerce cited national security concerns tied to Chinese technology in its decision. Polestar plans to shift its future focus toward European markets as access to new U.S. vehicle sales is restricted. Polestar Automotive Holding UK, listed as NasdaqGM:PSNY, develops and sells premium electric vehicles, a...

In June 2026, Mobileye Global announced plans to expand beyond supplying self-driving technology by launching a fully owned, vertically integrated autonomous ride-hailing business in a major U.S. city from 2027, starting with about 100 robotaxis and aiming to scale materially over the following five years. This move shifts Mobileye closer to an end‑to‑end mobility operator, combining its Mobileye Drive system with Moovit’s massive user base and global multimodal mobility platform into a...

Short-term traders and long-term holders alike may be asking the same question about International Business Machines right now: is the current share price giving you fair value for the risk you are taking? Over the past week the stock gained 3.7%, and it is up 3.0% over the last month, even though the year to date return is down 11.4% and the 1 year return is down 9.3%, compared to a much stronger 112.2% return over 3 years and 123.9% over 5 years. Recent headlines around International...

Brown & Brown (NYSE:BRO) has been recognized in 2026 for its workplace culture and mental health programs. The company was named to the Best Workplaces in Financial Services & Insurance and Best Workplaces for Mental Wellness lists. It also received the Platinum Level Bell Seal for Workplace Mental Health for the fourth consecutive year. Brown & Brown, trading at $60.83, is drawing attention for company culture as much as for its role in the insurance sector. The stock has risen 2.9% over...

Aurinia Pharmaceuticals recently highlighted progress in broadening its autoimmune portfolio, advancing aritinercept in clinical development and integrating Kezar Life Sciences’ zetomipzomib program following its acquisition. This move shifts Aurinia’s story from dependence on Lupkynis alone toward a more diversified pipeline that could reshape its long-term autoimmune footprint. We’ll now consider how this broadened autoimmune pipeline, particularly the addition of zetomipzomib, may...

Recent Share Performance and Business Profile Universal Health Services (UHS) has not been tied to a specific fresh headline event, but the stock’s recent performance and business mix across acute care and behavioral health services give investors several data points to assess. The company operates hospitals and behavioral health facilities across the United States, with revenue of about $17.76b and net income of roughly $1.52b, supported by both Acute Care Hospital Services and Behavioral...

EnerSys (ENS) has drawn investor attention after launching its EZSelect Lite battery room management system in Switzerland, aiming to automate battery selection and monitoring for industrial users and address inefficiencies in large fleet operations. See our latest analysis for EnerSys. The EZSelect Lite launch lands as EnerSys trades at US$226.34 per share, with a 1 day share price return of 3.38%, a 90 day share price return of 32.08% and a 1 year total shareholder return of 164.17%...

Mixed expectations ahead of Constellation Brands earnings Constellation Brands (STZ) is back in focus as investors look ahead to its upcoming first quarter fiscal 2027 earnings release, with forecasts pointing to modest profit growth but softer expectations after recent EPS estimate revisions. See our latest analysis for Constellation Brands. Constellation Brands shares recently moved up with a 1-day share price return of 1% and a 7-day share price return of 2.32%, although the 1-year total...